search icon
mltx-img

MoonLake Immunotherapeutics, Common Stock

MLTX

NAQ

$46.5

+$1.24

(2.74%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$2.93B
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
374.23K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.28
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$37.55 L
$64.98 H
$46.5

About MoonLake Immunotherapeutics, Common Stock

MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It develops Sonelokimab, a novel investigational Nanobody for the treatment of inflammation diseases; and hidradenitis suppurativa, psoriatic arthritis, axial spondyloarthritis, and psoriasis. MoonLake Immunotherapeutics was founded in 2021 and is headquartered in Zug, Switzerland. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameMLTXSectorS&P500
1-Week Return-7.39%0.31%-1.26%
1-Month Return-12.23%0.6%-4.16%
3-Month Return-4.91%-9.44%-0.46%
6-Month Return-4.91%-5.15%3.58%
1-Year Return-19.35%0.33%22.47%
3-Year Return370.17%4.53%25.13%
5-Year Return343.28%35.98%77.7%

Financials

Dec '20Dec '21Dec '22Dec '23
Total Revenue----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Cost of Revenue-4.97K12.36K13.16K[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":37.78,"profit":true},{"date":"2022-12-31","value":93.92,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Profit-(4.97K)(12.36K)(13.16K)[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-497100,"profit":false},{"date":"2022-12-31","value":-1235800,"profit":false},{"date":"2023-12-31","value":-1315800,"profit":false}]
Gross Margin--(Infinity%)(Infinity%)[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false}]
Operating Expenses105.75K4.57M65.06M54.12M[{"date":"2020-12-31","value":0.16,"profit":true},{"date":"2021-12-31","value":7.02,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":83.19,"profit":true}]
Operating Income(105.76K)(4.57M)(65.06M)(54.12M)[{"date":"2020-12-31","value":-10576000,"profit":false},{"date":"2021-12-31","value":-457034500,"profit":false},{"date":"2022-12-31","value":-6506141700,"profit":false},{"date":"2023-12-31","value":-5412309600,"profit":false}]
Total Non-Operating Income/Expense----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Pre-Tax Income(90.84K)(4.54M)(64.47M)(43.98M)[{"date":"2020-12-31","value":-9083800,"profit":false},{"date":"2021-12-31","value":-454265400,"profit":false},{"date":"2022-12-31","value":-6446968500,"profit":false},{"date":"2023-12-31","value":-4398472900,"profit":false}]
Income Taxes(206.30K)5.71K36.37K94.39K[{"date":"2020-12-31","value":-218.56,"profit":false},{"date":"2021-12-31","value":6.05,"profit":true},{"date":"2022-12-31","value":38.53,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Income After Taxes----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Income From Continuous Operations-(4.54M)(50.10M)(52.66M)[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":-454265400,"profit":false},{"date":"2022-12-31","value":-5009810700,"profit":false},{"date":"2023-12-31","value":-5265965700,"profit":false}]
Income From Discontinued Operations----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(90.84K)(4.54M)(64.51M)(36.01M)[{"date":"2020-12-31","value":-9083800,"profit":false},{"date":"2021-12-31","value":-454265400,"profit":false},{"date":"2022-12-31","value":-6450605100,"profit":false},{"date":"2023-12-31","value":-3600726000,"profit":false}]
EPS (Diluted)(0.01)(0.31)(1.27)(0.76)[{"date":"2020-12-31","value":-1,"profit":false},{"date":"2021-12-31","value":-31,"profit":false},{"date":"2022-12-31","value":-127,"profit":false},{"date":"2023-12-31","value":-76,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

MLTX
Cash Ratio 24.60
Current Ratio 25.51

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

MLTX
ROA (LTM) -13.32%
ROE (LTM) -16.80%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

MLTX
Debt Ratio Lower is generally better. Negative is bad. 0.04
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.94

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

MLTX
Trailing PE NM
Forward PE NM
P/S (TTM) 0.00
P/B 6.01
Price/FCF NM
EV/R 0.00
EV/Ebitda NM

FAQs

What is MoonLake Immunotherapeutics share price today?

MoonLake Immunotherapeutics (MLTX) share price today is $46.5

Can Indians buy MoonLake Immunotherapeutics shares?

Yes, Indians can buy shares of MoonLake Immunotherapeutics (MLTX) on Vested. To buy MoonLake Immunotherapeutics from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in MLTX stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of MoonLake Immunotherapeutics be purchased?

Yes, you can purchase fractional shares of MoonLake Immunotherapeutics (MLTX) via the Vested app. You can start investing in MoonLake Immunotherapeutics (MLTX) with a minimum investment of $1.

How to invest in MoonLake Immunotherapeutics shares from India?

You can invest in shares of MoonLake Immunotherapeutics (MLTX) via Vested in three simple steps:

  • Click on Sign Up or Invest in MLTX stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in MoonLake Immunotherapeutics shares
What is MoonLake Immunotherapeutics 52-week high and low stock price?

The 52-week high price of MoonLake Immunotherapeutics (MLTX) is $64.98. The 52-week low price of MoonLake Immunotherapeutics (MLTX) is $37.55.

What is MoonLake Immunotherapeutics price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of MoonLake Immunotherapeutics (MLTX) is

What is MoonLake Immunotherapeutics price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of MoonLake Immunotherapeutics (MLTX) is 6.01

What is MoonLake Immunotherapeutics dividend yield?

The dividend yield of MoonLake Immunotherapeutics (MLTX) is 0.00%

What is the Market Cap of MoonLake Immunotherapeutics?

The market capitalization of MoonLake Immunotherapeutics (MLTX) is $2.93B

What is MoonLake Immunotherapeutics’s stock symbol?

The stock symbol (or ticker) of MoonLake Immunotherapeutics is MLTX

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top